Shenzhen BinDeBio Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Shanghai China (2009)

Organization Overview

First Clinical Trial
2016
NCT03265106
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Shenzhen BinDeBio Ltd. | Shenzhen BinDeBio Tech Co.,Ltd